A New Antileishmanial Preparation of Combined Solamargine and Solasonine Heals Cutaneous Leishmaniasis through Different Immunochemical Pathways

Little has been done during the past 100 years to develop new antileishmanial drugs. Most infected individuals live in poor countries and have a low cash income to be attractive targets to pharmaceutical corporations. Two heterosidic steroids, solamargine and solasonine, initially identified as majo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antimicrob Agents Chemother
Hauptverfasser: Lezama-Dávila, C. M., McChesney, J. D., Bastos, J. K., Miranda, M. A., Tiossi, R. F., da Costa, J. de C., Bentley, M. V., Gaitan-Puch, S. E., Isaac-Márquez, A. P.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2016
Schlagworte:
Experimental Therapeutics
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4862480/
https://ncbi.nlm.nih.gov/pubmed/26883711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02804-15
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge